Global Neuromodulation Devices Market Research Report by Procedure and Geography

Document Sample
Global Neuromodulation Devices Market Research Report by Procedure and Geography Powered By Docstoc
					                           ReportsnReports
                              Presented




      Neuromodulation Market – [Spinal Cord Stimulation (SCS), Vagus Nerve
  Stimulation (VNS), Gastric Electrical Stimulation (GES), Deep Brain Stimulation
(DBS), Sacral Nerve Stimulation (SNS) & Transcranial Magnetic Stimulation (TMS)]
                                – Forecasts to 2017
New market research Report on “Neuromodulation Market – [Spinal Cord Stimulation (SCS), Vagus
Nerve Stimulation (VNS), Gastric Electrical Stimulation (GES), Deep Brain Stimulation (DBS), Sacral
Nerve Stimulation (SNS) & Transcranial Magnetic Stimulation (TMS)] – Forecasts to 2017” added to
ReportsnReports.com

Neuromodulation devices have emerged as one of the fastest growing segments of the medical device market
due to high demand for minimally invasive and non–invasive treatment. With advancements in technology,
neuromodulation is expected to become a promising therapeutic area and high growth industry in the next
decade, as it offers symptomatic relief mainly from chronic pain, incontinence, heart failure, headache,
depression, epilepsy, etc. The neuromodulation devices market includes deep brain stimulation, spinal cord
stimulation, vagus nerve stimulation, sacral nerve stimulation and others external stimulation devices such as
transcranial magnetic stimulation, and transcutaneous electrical nerve stimulation (TENS).

The neuromodulation technique acts directly upon nerves or the target area where the activity of nerves is
altered due to biological responses produced by electrical stimulation or drug infusion. These devices include
small electrodes that are attached to the brain, the spinal cord, or peripheral nerves. These precisely placed
leads are connected by means of an extension cable to a pulse generator to generate electrical stimulation.
Neuromodulation can have applications in any area of the body and can treat several diseases like chronic pain,
epilepsy, psychiatric disorder, movement disorder, cardiovascular disorder, genitourinary and colorectal disorder,
stroke and brain injury, and gastric disorder.

Request a sample of this report @
http://www.reportsnreports.com/contacts/RequestSample.aspx?name=214982.
The main drivers for the neuromodulation market are the rising population of aged people and age -related
diseases like Alzheimer’s, epilepsy, spinal cord injury, and Parkinson’s disease. According to the International
Neuromodulation Society, about 40 million to 50 million patients worldwide suffer from epilepsy, and 1.5 million
people currently (2012) suffer from Parkinson disease in the U.S. The large pool of patients that suffer from
depression, stroke, anxiety disorders, lower back pain, urinary incontinence, and tremor offers the
neuromodulation industry opportunities to grow in the next five years. The market for treatment of tinnitus, in
particular, represents an emerging application of neuromodulation. According to the American Tinnitus
Association, about 50 million people currently (2012) suffer from this disease in the U.S.

This report estimates the market for six major segments, namely, spinal cord stimulation, deep brain
stimulation, sacral nerve stimulation, vagus nerve stimulation, gastric electrical stimulation, transcranial
magnetic stimulation, and others. The report also estimates the market for different neuromodulation
techniques as well as geographic analysis of each segment in North America, Europe, Asia -Pacific, and Rest
of the World. As technologies develop and the number of trained physician increases, the likelihood of
neuromodulation being seen as life-changing treatment will increase dramatically. It is estimated that the
market for neuromodulation will be shared largely by deep brain stimulation and spinal cord stimulation.

The key players in the neuromodulation devices market are Medtronic, Inc. (U.S.), Cyberonics, Inc. (U.S.),
Boston Scientific Corporation (U.S.), St. Jude Medical (U.S.), Enteromedics, Inc (U.S.), Neuropace, Inc (U.S.),
Zynex, Inc (U.S.) and Neuronetics, Inc (U.S.). The emerging players in this market are Functional
Neuromodulation, Ltd (U.S.), Microtransponder (U.S.), and Neurosigma, Inc (U.S.).

Buy a copy of this report @ http://www.reportsnreports.com/Purchase.aspx?name=214982.




                     Contact: sales@reportsandreports.com for further information.
                            About us ReportsnReports
ReportsnReports.com is your single source for all market research needs. Our database includes 100,000+
market research reports from over 95 leading global publishers & in-depth market research studies of over
5000 micro markets. We offer you customization options on reports by & custom reports through
MarketsandMarkets.com. With comprehensive information about the publishers and the industries for
which they publish market research reports, we help you in your purchase decision by mapping your
information needs with our huge collection of reports.

Contact us for your special interest needs and we will get in touch within 24hrs to help you find the market
research report you need.
With our expertise and research offerings, we ensure we deliver on all your requirements, whether you’re
looking for industry analysis or market trends or anything else, first time and every time!




                      Contact: sales@reportsandreports.com for further information.
    Contact us ReportsnReports


                    Corporate Office

          TX, Dallas North - Dominion Plaza,
                17304, Preston Road,
               Suite 800, Dallas 75252.
                   + 1 888 391 5441




Contact: sales@reportsandreports.com for further information.

				
DOCUMENT INFO
Description: This report estimates the market for six major segments, namely, spinal cord stimulation, deep brain stimulation, sacral nerve stimulation, vagus nerve stimulation, gastric electrical stimulation, transcranial magnetic stimulation, and others.